Equity Analysis /
United States of America

US : Viking Therapeutics, Inc. - VKTX | 2Q22 Update: Thinking Through Positioning Into MDGL Data (4Q22E) and GLP-1/GIP Data

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    28 July 2022
    Published byCGS-CIMB